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Adenocarcinoma of the ileum
Right hemicolectomyAbbreviations: SBA, small bowel adenocarcinoma
MRI, magnetic resonance imaging.
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Introduction: Primary small bowel malignancy is unusual and accounts for 1e3% of all gastrointestinal
tract neoplasms. Adenocarcinoma is one of the most common histologic types, but its frequency de-
creases with more distal locations. Its clinical presentation is nonspeciﬁc and is usually associated with
advanced disease, which contributes to delayed diagnosis.
Presentation of case: A 66-year-old woman was admitted to the hospital with a 6-day history of pro-
gressively worsening abdominal pain localized in the right lower quadrant, nausea, and vomiting.
Investigation revealed an inﬂammatory appendiceal tumor. The patient underwent surgery and an un-
expected tumor involving the distal ileal segment and ileocecal appendix was found. Right radical
hemicolectomy with en bloc resection of the distal ileum was performed. Histopathological examination
revealed adenocarcinoma of the ileum.
Discussion: This rare entity is associated with a nonspeciﬁc clinical presentation that contributes to
delayed diagnosis and treatment, and consequently to a worse prognosis. Approximately half of the cases
are only diagnosed at surgery. Primary treatment consists of wide resection with locoregional lym-
phadenectomy. The role of adjuvant chemotherapy has yet to be determined.
Conclusion: This case demonstrates an unusual condition characterized by late and challenging diag-
nosis. We highlight the importance of an earlier diagnosis and optimal treatment for improved patient
outcomes.
© 2015 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Limited. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Primary small bowel malignancy is rare, accounting for 1e3% of
all gastrointestinal tract neoplasms. The estimated annual inci-
dence is 2.1 cases per 100,000 persons and is increasing [1,2].
Currently, the most common histologic type is carcinoid (44%),; CT, computed tomography;
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(8%) [2].
Adenocarcinoma of the small bowel (SBA) is an even more rare
entity; it is most commonly located in the duodenum (57%),
jejunum (29%), and ileum (10%) [3]. Crohn disease and celiac dis-
ease are the most important known risk factors, but other associ-
ations may exist [2e4].
Adenocarcinoma's clinical presentation lacks speciﬁcity, which
contributes to an average delay of 6e10months in diagnosis [2,4,5].
The most common clinical manifestations are nonspeciﬁc:
abdominal pain, nausea, vomiting, bowel obstruction, occult GI
bleeding, and weight loss [4,5].oup Limited. This is an open access article under the CC BY-NC-ND license (http://
Fig. 2. CT scan image (axial view) showing periappendiceal fat stranding.
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nosis of small bowel tumors. Diagnostic studies include upper
gastrointestinal barium study (UGI), ultrasonography, computed
tomography (CT) scan, magnetic resonance imaging (MRI), video
capsule endoscopy, and double-balloon enteroscopy. However, in
30e60% of cases, the diagnosis is only established at surgery,
particularly for distally located SBA [3,4,6,7].
Surgery is the primary treatment for locoregionally limited SBA.
Wide resection with negative margins and regional lymphade-
nectomy with adequate lymph node evaluation appears to be the
best management. This differs for proximal duodenal tumors,
where pancreaticoduodenectomy should be performed, and distal
ileal tumors, where right hemicolectomy is indicated [2,8]. The role
of adjuvant chemotherapy is still unknown, and prospective studies
are needed to address this issue. Some retrospective studies have
shown improvement in disease-free survival with the use of
adjuvant therapy [6,9,10].2. Presentation of case
A 66-year-old Caucasian woman with a previous history of
dyslipidemia was admitted to the emergency department with a 6-
day history of progressively worsening abdominal pain localized in
the right lower quadrant, nausea, and vomiting; the vomiting
began one day before admission. Anorexia and unquantiﬁedweight
loss were also present. She had no fever, changes in bowel habits, or
urinary symptoms. Physical examination revealed that she was
vigilant, oriented, afebrile, and hemodynamically stable. Her
abdomen was non-distended, and she had right lower quadrant
pain on superﬁcial and deep palpation with tenderness but no
guarding or rebound tenderness. Rectal and gynecologic exami-
nations were unremarkable.
Laboratory testing showed no anemia (hemoglobin, 12.3  10 g/
L) or leukocytosis (white blood cell count, 6.82  109/L with 83.9%
neutrophils) but indicated elevated C-reactive protein (145.0 mg/L).
Abdominopelvic ultrasonographywas complementedwith non-
contrast-enhanced pelvic CT scan (Fig. 1 and Fig. 2); a 4-cm right
lower quadrant mass involving the ileocecal appendix and cecum
was identiﬁed. Appendiceal wall thickening and periappendiceal
fat stranding were evident. No intra-abdominal free ﬂuid, extra-
luminal air, or ﬂuid accumulation was observed.
A diagnosis of inﬂammatory appendiceal tumor was made, and
the patient underwent surgery. At laparotomy, a tumor involving
the distal ileal segment and ileocecal appendix was present. The
cecal wall was also thickened. There were multiple enlarged lymph
nodes in the mesenteric root. No other visible lesions were iden-
tiﬁed. We performed a right radical hemicolectomy with en blocFig. 1. CT scan image (axial view) showing appendiceal wall thickening.resection of the last 70 cm of the ileum and a primary stapled
ileocolic anastomosis (Fig. 3). No surgical complications were
perceived, so the patient was discharged on the ﬁfth postoperative
day.
Histopathological examination revealed a well-differentiated
adenocarcinoma of the ileum invading the mesenteric fat and
ileocecal appendix; free surgical margins were achieved. No lymph
node involvement was present. The tumor was pathologically
staged as pT4pN0. Complete staging was performed and revealed
no distant metastasis (M0): stage IIB disease [11].
After multidisciplinary consultation, adjuvant chemotherapy
was elected. The patient completed 8 cycles of capecitabine withFig. 3. Resected specimen e right hemicolectomy with en bloc resection of distal
ileum. Tumor involving ileal segment and ileocecal appendix is noticeable.
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there has been no evidence of recurrent disease.
3. Discussion
Adenocarcinoma of the ileum is a gastrointestinal tumor with a
low incidence. Some risk factors are known (e.g., Crohn disease and
celiac disease), but many others have only been postulated and are
also associated with colorectal cancer. The clinical presentation is
nonspeciﬁc, and the ﬁrst symptoms are usually related to advanced
disease. The most common symptoms e abdominal pain, nausea,
and vomiting e are frequently present with the majority of intra-
abdominal conditions. These factors contribute to delayed diag-
nosis and treatment, and consequently to a worse prognosis.
The most frequently used and reliable diagnostic exam is
contrast-enhanced CT scan with appropriate IV and oral protocols,
while non-contrast-enhanced CT scan has an inferior accuracy rate
“[12].” Many other modalities have also been used. Endoscopic
studies, such as double-balloon enteroscopy or video capsule
endoscopy, are being increasingly used [13]. Nevertheless,
approximately half of the cases are only diagnosed at surgery,
mostly because of misdiagnosis.
Currently, the best treatment for this neoplasm is wide resection
with lymphadenectomy. When the tumor is located in the distal
ileum, a right radical hemicolectomy is preferred to ensure free
surgical margins. The role of adjuvant chemotherapy has yet to be
determined, especially with regard to the beneﬁts by stage and the
ideal therapeutic schema [9].
The outcomes from large studies have shown that, for patients
with stage II to III disease who are treated with surgical resection,
5-year overall survival rates range from 27 to 52% [9,14]. These poor
outcomes make early diagnosis even more important.
4. Conclusion
Adenocarcinoma of the distal ileum is uncommon and chal-
lenging to diagnose, as symptoms are usually late and nonspeciﬁc.
Right lower quadrant pain is the most frequent symptom, which
raises many other more likely conditions as differential diagnoses.
CT scan is frequently used after common gastrointestinal disorders
have been ruled out, and particularly in elderly patients where the
risk of malignancy is higher. However, approximately half of the
cases are only diagnosed during surgery. Wide resection with
lymphadenectomy is the main treatment; right radical hemi-
colectomy is the most frequently chosen procedure. The role of
adjuvant chemotherapy has not yet been determined. In general,
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